Researcher Arnon Kater (Internal Medicine) has been awarded an ERC Proof of Concept Grant of EUR 150,000. This funding from the European Research Council (ERC) will enable Arnon Kater to investigate the commercial or societal potential of his project entitled 'Technical and commercial feasibility of two CD2-based T cell therapies against CLL'. The ERC, founded by the European Union in 2007, funds creative researchers of all nationalities and ages to carry out projects across Europe.